Remove Bioequivalency Remove Contamination Remove In-Vitro Remove Marketing
article thumbnail

Topical products: Aiming for quality, simplicity, and cost-efficiency in their development, scale-up, and manufacturing

Pharmaceutical Technology

It is important for a CDMO to understand the market it serves and, in the dermatologic arena, that means the demand for topical agents across a broad array of indications. In vitro release testing to demonstrate bioequivalence. Expertise in analytical testing, validation, and quality control are also essential.